• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

热带利什曼原虫:用与合成佐剂胞壁酰二肽交联的排泄因子接种的C3H小鼠的保护性反应。

Leishmania tropica: protective response in C3H mice vaccinated with excreted factor crosslinked with the synthetic adjuvant, muramyl dipeptide.

作者信息

Steinberger A, Slutzky G M, El-On J, Greenblatt C L

出版信息

Exp Parasitol. 1984 Dec;58(3):223-9. doi: 10.1016/0014-4894(84)90038-9.

DOI:10.1016/0014-4894(84)90038-9
PMID:6499996
Abstract

Excreted factor, an immunosuppressive, acidic polysaccharide released by promastigotes of Leishmania tropica major in culture, was chemically crosslinked to the synthetic adjuvant muramyl dipeptide via the bifunctional imidoester dimethyladipimidate and poly-L-lysine. This conjugate, an uncrosslinked mixture of the components, or each of the components alone were injected one to three times into different groups of 8- to 12-week-old C3H mice. The mice were challenged 2 weeks after the last injection with 2 X 10(6) promastigotes of L. t. major in the base of the tail. For the next 5 weeks, the animals were monitored for number of parasites and size of the lesion which developed at the site of the challenge. Mice receiving one intraperitoneal injection of the conjugate were partially protected against challenge. Treated animals had higher initial parasite numbers but showed a more rapid clearing of the parasites. Furthermore, the treated animals developed smaller lesions that healed quicker than did those of the control groups. Multiple injections, or injection into a footpad, rather than intraperitoneally, reduced the ability to elicit a protective response. On the other hand, muramyl dipeptide injected into a footpad was partially protective. Antibody production to excreted factor, which was measured by indirect hemagglutination of sensitized erythrocytes, was detected after challenge in mice which had received conjugate or conjugate components. A delayed hypersensitivity reaction (measured by skin testing) was not detected in any of the groups prior to challenge.

摘要

排泄因子是热带利什曼原虫前鞭毛体在培养过程中释放的一种免疫抑制性酸性多糖,通过双功能亚胺酯二甲基己二酰亚胺和聚-L-赖氨酸与合成佐剂胞壁酰二肽进行化学交联。将这种缀合物、各成分的未交联混合物或单独的各成分分别注射1至3次到不同组的8至12周龄C3H小鼠体内。在最后一次注射后2周,用2×10⁶个热带利什曼原虫前鞭毛体在小鼠尾巴根部进行攻击。在接下来的5周内,监测动物体内寄生虫数量以及攻击部位出现的病变大小。接受一次腹腔注射缀合物的小鼠对攻击有部分保护作用。经处理的动物初始寄生虫数量较多,但寄生虫清除速度更快。此外,经处理的动物出现的病变较小,愈合速度比对照组更快。多次注射或注射到脚垫而非腹腔内会降低引发保护反应的能力。另一方面,注射到脚垫的胞壁酰二肽有部分保护作用。在接受缀合物或缀合物成分的小鼠受到攻击后,通过致敏红细胞间接血凝法检测到对排泄因子的抗体产生。在攻击前,任何一组均未检测到迟发型超敏反应(通过皮肤试验测量)。

相似文献

1
Leishmania tropica: protective response in C3H mice vaccinated with excreted factor crosslinked with the synthetic adjuvant, muramyl dipeptide.热带利什曼原虫:用与合成佐剂胞壁酰二肽交联的排泄因子接种的C3H小鼠的保护性反应。
Exp Parasitol. 1984 Dec;58(3):223-9. doi: 10.1016/0014-4894(84)90038-9.
2
Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.在法国流行地区使用LiESAp-MDP疫苗对犬内脏利什曼病进行长期保护:双盲随机疗效现场试验。
Vaccine. 2007 May 22;25(21):4223-34. doi: 10.1016/j.vaccine.2007.02.083. Epub 2007 Mar 15.
3
Vaccination against cutaneous leishmaniasis in mice using nonpathogenic cloned promastigotes of Leishmania major and importance of route of injection.使用利什曼原虫主要种的非致病性克隆前鞭毛体对小鼠进行皮肤利什曼病疫苗接种及注射途径的重要性
Aust J Exp Biol Med Sci. 1984 Apr;62 ( Pt 2):145-53. doi: 10.1038/icb.1984.14.
4
Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes.鼠模型中皮肤利什曼病的疫苗接种。I. 前鞭毛体可溶性提取物诱导保护性免疫
J Immunol. 1987 Jul 1;139(1):221-7.
5
The potency and durability of DNA- and protein-based vaccines against Leishmania major evaluated using low-dose, intradermal challenge.使用低剂量皮内攻击法评估基于DNA和蛋白质的针对硕大利什曼原虫疫苗的效力和持久性。
J Immunol. 2001 Apr 15;166(8):5122-8. doi: 10.4049/jimmunol.166.8.5122.
6
Leishmania tropica major in mice: vaccination against cutaneous leishmaniasis in mice of high genetic susceptibility.热带利什曼原虫(硕大利什曼原虫)感染小鼠:对高遗传易感性小鼠进行皮肤利什曼病疫苗接种。
Aust J Exp Biol Med Sci. 1983 Feb;61(Pt 1):11-25. doi: 10.1038/icb.1983.2.
7
Leishmania infecting man and wild animals in Saudi Arabia. 8. The influence of prior infection with Leishmania arabica on challenge with L. major in man.
Trans R Soc Trop Med Hyg. 1990 Sep-Oct;84(5):681-9. doi: 10.1016/0035-9203(90)90145-5.
8
Experimental Leishmania (L.) amazonensis leishmaniasis: characterization and immunogenicity of subcellular fractions.实验性亚马逊利什曼原虫利什曼病:亚细胞组分的特性与免疫原性
Immunol Invest. 2007;36(4):473-92. doi: 10.1080/08820130701360972.
9
Total Leishmania antigens with Poly(I:C) induce Th1 protective response.利什曼原虫全抗原与聚肌胞苷酸诱导Th1保护性应答。
Parasite Immunol. 2017 Nov;39(11). doi: 10.1111/pim.12491. Epub 2017 Oct 9.
10
The cellular and humoral immune response in subjects vaccinated against cutaneous leishmaniasis using Leishmania tropica major promastigotes.使用热带利什曼原虫前鞭毛体对皮肤利什曼病进行疫苗接种的受试者的细胞免疫和体液免疫反应。
Parasite Immunol. 1983 Jul;5(4):337-44. doi: 10.1111/j.1365-3024.1983.tb00749.x.

引用本文的文献

1
Immunization with Leishmania receptor for macrophages protects mice against cutaneous leishmaniasis.巨噬细胞利什曼原虫受体免疫可保护小鼠免受皮肤利什曼病感染。
Proc Natl Acad Sci U S A. 1985 Sep;82(17):5910-4. doi: 10.1073/pnas.82.17.5910.
2
Occurrence of autoantibodies to intermediate filament proteins in human visceral leishmaniasis and their induction by experimental polyclonal B-cell activation.人体内脏利什曼病中针对中间丝蛋白自身抗体的出现及其由实验性多克隆B细胞激活诱导产生的情况。
Immunology. 1986 Dec;59(4):583-8.
3
Vaccine-induced immunity against cutaneous leishmaniasis in BALB/c mice.
疫苗诱导BALB/c小鼠对皮肤利什曼病的免疫力。
Infect Immun. 1988 Apr;56(4):843-8. doi: 10.1128/iai.56.4.843-848.1988.